NIGP 26904: Antihistamine Drugs

NIGP 26904 Antihistamine Drugs is an Item code that encompasses pharmaceutical procurement by state and local governments, though recent solicitation activity under this code reflects a broader scope of pharmaceutical and drug-related services than the legacy description suggests. State and local governments are buying naloxone (an opioid antagonist), safe drug deactivation systems, tuberculosis housing services with embedded healthcare coordination, and on-site pharmacy services to support public health initiatives and employee health plans. The buying bodies include county health departments, state health agencies, and county government employee health plans. Issuing bodies range across health departments (Seminole County, Florida and Utah Department of Health and Human Services), county government employers (Hall County, Georgia), and homeless health service nonprofits supported through state contracts.

Recent opportunities span Florida, Utah, and Georgia. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, response due July 26, 2026. The Utah Department of Health and Human Services pursued Amendment 4 to Contract 236102 with Wasatch Homeless Health Care for tuberculosis housing services, a sole-source award with a public challenge period closing June 26, 2026, increasing funding to $186,044 for the fiscal year July 1, 2026 through June 30, 2027. Hall County, Georgia issued RFQ/P #47-010 in May 2026 for on-site pharmacy services at its Family Health Center Clinic to serve approximately 3,005 covered lives across multiple health plan types, with sealed proposals due June 4, 2026, and contract start January 1, 2027. The Hall County procurement emphasizes technical qualifications (80% weight) over cost (20% weight), with mandatory insurance requirements including $2 million general liability and $1 million cyber liability coverage.